Cas no 31373-65-6 (Hippuryl-L-histidyl-L-leucine)
Hippuryl-L-histidyl-L-leucine Chemical and Physical Properties
Names and Identifiers
-
- L-Leucine,N-benzoylglycyl-L-histidyl-
- HIPPURYL-HIS-LEU
- Hippuryl-His-Leu-OH
- HIPPURYL-L-HISTIDYL-L-LEUCINE
- BENZOYL-GLY-HIS-LEU
- Bz-Gly-His-Leu
- BZ-GLY-HIS-LEU-OH
- H-HIP-HIS-LEU-OH
- HIPPURYL-HISTIDYL-LEUCINE
- hippuryl-L-histdyl-L-leucine
- hippuryl-L-histidinyl-L-leucine
- N-Benzoyl-Gly-L-His-L-Leu-OH
- N-hippuryl-His-Leu
- (2S)-2-[(2S)-3-(1H-imidazol-4-yl)-2-[2-(phenylformamido)acetamido]propanamido]-4-methylpentanoic acid
- benzoylglycyl-L-histidyl-L-leucine
- n-hippuryl-l-histidyl-l-leucine
- benzoyl-glycyl-histidyl-leucine
- Hippuryl-His-Leu-OH (BZ-Gly-L-His-L-Leu-OH)
- H1711
- EINECS 250-597-9
- 1212823-14-7
- N-{1-Hydroxy-2-[(1-hydroxy-2-{[hydroxy(phenyl)methylidene]amino}ethylidene)amino]-3-(1H-imidazol-5-yl)propylidene}leucine
- DTXSID30953414
- NS00050799
- HY-P4551
- J-013566
- 31373-65-6
- (2S)-2-[[(2S)-2-[(2-benzamidoacetyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoic acid
- SCHEMBL21925037
- CS-0655091
- N-Benzoyl-Gly-His-Leu
- N-[2-([(Benzoylamino)acetyl]amino)-3-(1H-imidazol-4-yl)propanoyl]leucine #
- MFCD00005205
- (S)-2-((S)-2-(2-Benzamidoacetamido)-3-(1H-imidazol-4-yl)propanamido)-4-methylpentanoic acid
- N-Hippuryl-L-histidyl-L-leucine hydrate
- SCHEMBL1275443
- N-(N-(N-benzoylglycyl)-L-histidinyl)-L-leucine
- N-(N-(N-Benzoylglycyl)-L-histidyl)-L-leucine
- rel-(S)-2-((S)-2-(2-benzamidoacetamido)-3-(1h-imidazol-4-yl)propanamido)-4-methylpentanoic acid
- L-Leucine, N-[N-(N-benzoylglycyl)-L-histidyl]-
- Hip-His-Leu
- L-Leucine, N-(N-(N-benzoylglycyl)-L-histidyl)-
- DA-64169
- G87036
- Hippuryl-L-histidyl-L-leucine
-
- MDL: MFCD00005205
- Inchi: 1S/C21H27N5O5/c1-13(2)8-17(21(30)31)26-20(29)16(9-15-10-22-12-24-15)25-18(27)11-23-19(28)14-6-4-3-5-7-14/h3-7,10,12-13,16-17H,8-9,11H2,1-2H3,(H,22,24)(H,23,28)(H,25,27)(H,26,29)(H,30,31)/t16-,17-/m0/s1
- InChI Key: AAXWBCKQYLBQKY-IRXDYDNUSA-N
- SMILES: O=C([C@H](CC1=CN=CN1)NC(CNC(C1C=CC=CC=1)=O)=O)N[C@H](C(=O)O)CC(C)C
Computed Properties
- Exact Mass: 429.20100
- Monoisotopic Mass: 429.20121898g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 9
- Hydrogen Bond Acceptor Count: 14
- Heavy Atom Count: 35
- Rotatable Bond Count: 14
- Complexity: 636
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 2
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: 16
- XLogP3: 1.4
- Topological Polar Surface Area: 153
Experimental Properties
- Color/Form: White powder
- Solubility: acetic acid: 50?mg/mL, clear, colorless
- PSA: 153.28000
- LogP: 1.65520
- Solubility: acetic acid
Hippuryl-L-histidyl-L-leucine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | H347015-50mg |
Hippuryl-L-histidyl-L-leucine |
31373-65-6 | 50mg |
$ 50.00 | 2022-06-04 | ||
| TRC | H347015-100mg |
Hippuryl-L-histidyl-L-leucine |
31373-65-6 | 100mg |
$115.00 | 2023-05-18 | ||
| TRC | H347015-500mg |
Hippuryl-L-histidyl-L-leucine |
31373-65-6 | 500mg |
$517.00 | 2023-05-18 | ||
| abcr | AB478297-250 mg |
Hippuryl-His-Leu-OH; . |
31373-65-6 | 250MG |
€154.50 | 2022-05-20 | ||
| abcr | AB478297-1 g |
Hippuryl-His-Leu-OH; . |
31373-65-6 | 1g |
€362.00 | 2022-05-20 | ||
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | H923235-5mg |
Hippuryl-L-histidyl-L-leucine |
31373-65-6 | 98% | 5mg |
¥315.00 | 2022-01-14 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | H923235-25mg |
Hippuryl-L-histidyl-L-leucine |
31373-65-6 | 98% | 25mg |
¥1,103.00 | 2022-01-14 | |
| TRC | H347015-1g |
Hippuryl-L-histidyl-L-leucine |
31373-65-6 | 1g |
$919.00 | 2023-05-18 | ||
| abcr | AB478297-250mg |
Hippuryl-His-Leu-OH (Bz-Gly-L-His-L-Leu-OH); . |
31373-65-6 | 250mg |
€154.50 | 2024-08-03 | ||
| abcr | AB478297-1g |
Hippuryl-His-Leu-OH (Bz-Gly-L-His-L-Leu-OH); . |
31373-65-6 | 1g |
€362.00 | 2024-08-03 |
Hippuryl-L-histidyl-L-leucine Suppliers
Hippuryl-L-histidyl-L-leucine Related Literature
-
1. Ultraviolet–circular dichroism spectra for structural analysis of copper(II) complexes with aliphatic and aromatic ligands in aqueous solutionPier G. Daniele,Enrico Prenesti,Giorgio Ostacoli J. Chem. Soc. Dalton Trans. 1996 3269
-
Hanane Amrani-Allalou,Lila Boulekbache-Makhlouf,Luana Izzo,Lynda Arkoub-Djermoune,Mohamed Lamine Freidja,Khokha Mouhoubi,Khodir Madani,Gian Carlo Tenore Food Funct. 2021 12 1291
-
Zhipeng Yu,Sijia Wu,Wenzhu Zhao,Long Ding,David Shiuan,Feng Chen,Jianrong Li,Jingbo Liu Food Funct. 2018 9 364
-
Zhipeng Yu,Wenzhu Zhao,Long Ding,Yiding Yu,Jingbo Liu Food Funct. 2016 7 491
-
5. A comprehensive review of bioactive peptides obtained from animal byproducts and their applicationsJulia Bechaux,Philippe Gatellier,Jean-Fran?ois Le Page,Yoan Drillet,Véronique Sante-Lhoutellier Food Funct. 2019 10 6244
Additional information on Hippuryl-L-histidyl-L-leucine
Comprehensive Analysis of Hippuryl-L-histidyl-L-leucine (CAS No. 31373-65-6): Applications and Research Insights
Hippuryl-L-histidyl-L-leucine (CAS No. 31373-65-6) is a synthetic tripeptide compound that has garnered significant attention in biochemical and pharmaceutical research. This peptide, composed of hippuric acid, L-histidine, and L-leucine, serves as a critical substrate for enzyme studies, particularly in the evaluation of angiotensin-converting enzyme (ACE) activity. Its unique structure and functional properties make it a valuable tool for researchers exploring cardiovascular health, enzyme kinetics, and peptide-based therapeutics.
In recent years, the demand for Hippuryl-L-histidyl-L-leucine has surged due to its role in biomedical research and drug development. With the growing focus on precision medicine and personalized therapies, this compound has become a focal point for studies investigating ACE inhibitors and their potential applications in managing hypertension and metabolic disorders. Researchers are also exploring its utility in diagnostic assays, where it aids in the quantification of enzyme activity and the screening of novel therapeutic agents.
The synthesis and purification of Hippuryl-L-histidyl-L-leucine require advanced techniques such as solid-phase peptide synthesis (SPPS) and high-performance liquid chromatography (HPLC). These methods ensure high purity and consistency, which are essential for reproducible experimental results. The compound's stability under various pH conditions and its solubility in aqueous solutions further enhance its practicality in laboratory settings.
From a commercial perspective, Hippuryl-L-histidyl-L-leucine is available through specialized biochemical suppliers and research reagent providers. Its pricing and availability are influenced by factors such as production scale, purity grade, and market demand. As the life sciences industry continues to expand, the compound's relevance in academic research and industrial applications is expected to grow.
In conclusion, Hippuryl-L-histidyl-L-leucine (CAS No. 31373-65-6) represents a versatile and indispensable component in modern biochemical research. Its applications span from enzyme assays to therapeutic development, aligning with contemporary trends in health innovation and scientific discovery. For researchers and industry professionals, understanding its properties and potential is key to unlocking new advancements in peptide science and molecular biology.
31373-65-6 (Hippuryl-L-histidyl-L-leucine) Related Products
- 5354-94-9(2-Benzoylamino-3-(1H-imidazol-4-yl)propionic Acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)